SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey

Oygar, PD; Buyukcam, A; Bal, ZS; Dalgic, N; Bozdemir, SE; Karbuz, A; Cetin, BS; Kara, Y; Cetin, C; Hatipoglu, N; Uygun, H; Aygun, FD; Torun, SH; Okur, DS; Ciftdogan, DY; Kara, TT; Yahsi, A; Ozer, A; Demir, SO; Akkoc, G; Turan, C; Sali, E; Sen, S; Erdeniz, EH; Kara, SS; Emiroglu, M; Erat, T; Akturk, H; Gurlevik, SL; Sutcu, M; Aydin, ZGG; Atikan, BY; Yesil, E; Guner, G; Celebi, E; Efe, K; Isancli, DK; Durmus, HS; Tekeli, S; Karaaslan, A; Bulbul, L; Almis, H; Kaba, O; Keles, YE; Yazicioglu, B; Oguz, SB; Ovali, HF; Dogan, HH; Celebi, S; Cakir, D; Karasulu, B; Alkan, G; Yenidogan, I; Gul, D; Kucukalioglu, BP; Avcu, G; Kukul, MG; Bilen, M; Yasar, B; Ustun, T; Kilic, O; Akin, Y; Cebeci, SO; Bucak, IH; Yanartas, MS; Sahin, A; Arslanoglu, S; Elevli, M; Coban, R; Oz, SKT; Hatipoglu, H; Erkum, IT; Turgut, M; Demirbuga, A; Ozcelik, T; Ciftci, D; Sari, EE; Akkus, G; Hatipoglu, SS; Dinleyici, EC; Hacimustafaoglu, M; Ozkinay, F; Kurugol, Z; Cengiz, AB; Somer, A; Tezer, H; Kara, A

Tarih

DEC
2021

Yazar

Oygar, PD; Buyukcam, A; Bal, ZS; Dalgic, N; Bozdemir, SE; Karbuz, A; Cetin, BS; Kara, Y; Cetin, C; Hatipoglu, N; Uygun, H; Aygun, FD; Torun, SH; Okur, DS; Ciftdogan, DY; Kara, TT; Yahsi, A; Ozer, A; Demir, SO; Akkoc, G; Turan, C; Sali, E; Sen, S; Erdeniz, EH; Kara, SS; Emiroglu, M; Erat, T; Akturk, H; Gurlevik, SL; Sutcu, M; Aydin, ZGG; Atikan, BY; Yesil, E; Guner, G; Celebi, E; Efe, K; Isancli, DK; Durmus, HS; Tekeli, S; Karaaslan, A; Bulbul, L; Almis, H; Kaba, O; Keles, YE; Yazicioglu, B; Oguz, SB; Ovali, HF; Dogan, HH; Celebi, S; Cakir, D; Karasulu, B; Alkan, G; Yenidogan, I; Gul, D; Kucukalioglu, BP; Avcu, G; Kukul, MG; Bilen, M; Yasar, B; Ustun, T; Kilic, O; Akin, Y; Cebeci, SO; Bucak, IH; Yanartas, MS; Sahin, A; Arslanoglu, S; Elevli, M; Coban, R; Oz, SKT; Hatipoglu, H; Erkum, IT; Turgut, M; Demirbuga, A; Ozcelik, T; Ciftci, D; Sari, EE; Akkus, G; Hatipoglu, SS; Dinleyici, EC; Hacimustafaoglu, M; Ozkinay, F; Kurugol, Z; Cengiz, AB; Somer, A; Tezer, H; Kara, A

Üst veri

Tüm öğe kaydını göster

Özet

Background: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to ex-plore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of surveillance in the future. Methods: We enrolled 4927 health care personnel working in pediatric units at 32 hospitals from 7 different regions of Turkey in a study to determine SARS Co-V-2 seroprevalence after the first peak of the COVID-19 pandemic. A point of care serologic lateral flow rapid test kit for immunoglobulin (Ig)M/IgG was used. Seroprevalence and its association with demographic characteristics and possible risk factors were analyzed. Results: SARS-CoV-2 seropositivity prevalence in health care personnel tested was 6.1%. Seropositivity was more common among those who did not universally wear protective masks (10.6% vs 6.1%). Having a COVID-19-positive co-worker increased the likelihood of infection. The least and the most experienced personnel were more likely to be infected. Most of the seropositive health care personnel (68.0%) did not suspect that they had previously had COVID-19. Conclusions: Health surveillance for health care personnel involving routine point-of-care nucleic acid testing and monitoring personal protective equipment adherence are suggested as important strategies to protect health care personnel from COVID-19 and reduce nosocomial SARS-CoV-2 transmission. (C) 2021 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.

Bağlantı

http://hdl.handle.net/20.500.12481/14412

Koleksiyonlar

Web Of Science [8594]